ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 345 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,685,044 | -1.1% | 25,090 | -0.3% | 0.04% | +6.1% |
| Q2 2023 | $1,703,922 | -11.2% | 25,165 | -29.0% | 0.03% | -13.2% |
| Q1 2023 | $1,918,224 | -9.5% | 35,457 | 0.0% | 0.04% | -11.6% |
| Q4 2022 | $2,120,683 | +29.7% | 35,457 | -1.9% | 0.04% | +22.9% |
| Q3 2022 | $1,635,000 | -66.2% | 36,157 | -58.1% | 0.04% | -63.9% |
| Q2 2022 | $4,836,000 | -25.7% | 86,287 | -5.7% | 0.10% | -9.3% |
| Q1 2022 | $6,508,000 | -3.4% | 91,527 | -11.4% | 0.11% | +5.9% |
| Q4 2021 | $6,738,000 | -28.6% | 103,249 | -17.9% | 0.10% | -30.3% |
| Q3 2021 | $9,439,000 | -9.0% | 125,787 | -5.4% | 0.14% | -7.1% |
| Q2 2021 | $10,377,000 | -5.4% | 132,982 | -0.8% | 0.16% | -11.4% |
| Q1 2021 | $10,975,000 | -7.7% | 134,002 | -6.8% | 0.18% | -12.4% |
| Q4 2020 | $11,886,000 | +18.3% | 143,745 | -7.0% | 0.20% | +2.0% |
| Q3 2020 | $10,046,000 | – | 154,600 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |